Clinical trial
Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast…
NCT00376688 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00376688 |
|---|---|
| Title | Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer |
| Official title | Phase II Trial of CCI-779 (Temsirolimus) in Patients With Locally Advanced or Metastatic Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7 |
| Intervention type | Drug, Other |
| Interventions | Laboratory Biomarker Analysis, Temsirolimus |
| Enrollment | 31 |
| Start date | Jul 11, 2006 |
| Primary completion | Jun 12, 2008 |
| Completion | Dec 16, 2019 |
| First posted | Sep 15, 2006 |
| Last update posted | Feb 24, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: